| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 388 | 299 | 43 | 33 |
| Cost of goods sold | 242 | 25 | - | - |
| Gross profit | 146 | 274 | - | - |
| Research and development expenses | 378 | 336 | 312 | 878 |
| Selling and marketing expenses | 265 | 199 | 208 | 431 |
| General and administration expenses | 2,007 | 1,373 | 1,588 | 2,992 |
| Impairment of intangible assets | 152 | - | - | - |
| Total operating expenses | 2,802 | 1,908 | 2,108 | 4,301 |
| Operating loss | -2,656 | -1,634 | -2,065 | -4,268 |
| Interest and bank fees | 10 | 15 | - | - |
| Change in derivative fair value | - | 0 | -9,369 | - |
| Interest income | 29 | 30 | - | - |
| Other income (expense), net | -2 | -203 | -18 | 5 |
| Interest and bank fees | - | - | -128 | -24 |
| Loss on settlement | - | 0 | -1,353 | - |
| Unrealized gain (loss) on foreign exchange | - | -7 | 3 | -2 |
| Total other income (expense) | 17 | -195 | -10,865 | - |
| Loss before income tax | -2,639 | -1,829 | -12,930 | -4,289 |
| Income tax provision | - | 4 | - | - |
| Net loss and comprehensive loss | -2,639 | -1,833 | - | -4,289 |
| Deemed dividend on warrant inducement | - | 0 | - | - |
| Net loss and comprehensive loss attributable to common stockholders | -2,639 | -1,833 | - | - |
| Basic loss per share (in dollars per share) | -0.2 | -0.14 | -1.74 | -0.61 |
| Diluted loss per share (in dollars per share) | -0.2 | - | - | - |
| Weighted average number of shares of common stock outstanding, basic (in shares) | 13,497,668 | 12,668,550 | 9,956,933 | 7,080,897 |
| Weighted average number of shares of common stock outstanding, diluted (in shares) | 13,497,668 | - | - | - |
FIREFLY NEUROSCIENCE, INC. (AIFF)
FIREFLY NEUROSCIENCE, INC. (AIFF)